Large-scale testing (Phase 3)Study completedNCT00030771What this trial is testingPreoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsWho this might be right forLung Cancer Swiss Cancer Institute 232
Post-approval studies (Phase 4)Study completedNCT02151149What this trial is testingSafety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyWho this might be right forNon-Small Cell Lung CancerCarcinomaSquamous Cell Carcinoma+3 more Celgene 143
Early research (Phase 1)Study completedNCT00005630What this trial is testingVaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00081302What this trial is testingCetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerWho this might be right forLung Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03083808What this trial is testingPhase II Trial of Continuation Therapy in Advanced NSCLCWho this might be right forNon-Small-Cell Lung Cancer Greg Durm, MD 35
Large-scale testing (Phase 3)UnknownNCT00955695What this trial is testingRadiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer National Cancer Center, Korea 242
Large-scale testing (Phase 3)Study completedNCT00049543What this trial is testingGefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more National Cancer Institute (NCI) 503
Testing effectiveness (Phase 2)Study completedNCT00025285What this trial is testingCombination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Wake Forest University Health Sciences 46
Testing effectiveness (Phase 2)Study completedNCT03543813What this trial is testingPROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLWho this might be right forSolid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more CytomX Therapeutics 133
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Testing effectiveness (Phase 2)Ended earlyNCT00728845What this trial is testingHydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Medicine and Dentistry of New Jersey 8
Large-scale testing (Phase 3)Study completedNCT00002852What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+3 more National Cancer Institute (NCI) 500
Testing effectiveness (Phase 2)Study completedNCT00234052What this trial is testingCarboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Northwestern University 51
Early research (Phase 1)Study completedNCT00102505What this trial is testingMotexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small-Cell Lung CarcinomaCarcinoma, Bronchogenic Pharmacyclics LLC. 36
Testing effectiveness (Phase 2)Study completedNCT04010357What this trial is testingTargeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLCWho this might be right forSmall-cell Lung CancerLarge Cell Neuroendocrine Carcinoma of the LungExtrapulmonary Small Cell Carcinoma Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT06228066What this trial is testingLurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)Who this might be right forSmall Cell Carcinoma of the BladderHigh Grade Neuroendocrine Tumors of the Urinary Tract National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT04476797What this trial is testingPhase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLCWho this might be right forSBRTNSCLCNon-metastatic Galera Therapeutics, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03845296What this trial is testingRucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationLoss of Heterozygosity+8 more SWOG Cancer Research Network 64
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69